{"id":"NCT00257166","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)","officialTitle":"Four Week, Double-Blind, Placebo Controlled Phase III Trial Evaluating The Efficacy, Safety And Pharmacokinetics Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-01","primaryCompletion":"2007-07","completion":"2007-07","firstPosted":"2005-11-22","resultsPosted":"2013-07-19","lastUpdate":"2021-03-03"},"enrollment":238,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Bipolar Disorder"],"interventions":[{"type":"DRUG","name":"Ziprasidone oral capsules","otherNames":[]},{"type":"DRUG","name":"placebo oral capsules","otherNames":[]}],"arms":[{"label":"Ziprasidone oral capsules","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if flexibly-dosed ziprasidone is safe and effective for the treatment of children and adolescents (ages 10-17) with bipolar I disorder (manic or mixed).","primaryOutcome":{"measure":"Change From Baseline in Young Mania Rating Scale (YMRS) Score at Week 4","timeFrame":"Baseline, Week 4","effectByArm":[{"arm":"Ziprasidone","deltaMin":26.2,"sd":6.6},{"arm":"Placebo","deltaMin":27,"sd":6.6}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0005"}]},"eligibility":{"minAge":"10 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":50,"countries":["United States"]},"refs":{"pmids":["24111980"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A1281132&StudyName=Safety%20and%20efficacy%20of%20ziprasidone%20in%20children%20and%20adolescents%20with%20Bipolar%20I%20Disorder%20%28manic%20or%20mixed%29"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":149},"commonTop":["Sedation","Headache","Somnolence","Fatigue","Nausea"]}}